Based in Tucson, Arizona, Retina Associates is a retina-focused medical practice, associated with Dr. Cameron Javid and his work in ophthalmology. Retina Associates follows developments relevant to retinal conditions, including dry age-related macular degeneration (AMD) and geographic atrophy.

At Retina Associates, geographic atrophy information includes FDA-approved therapies such as Izervay, an intravitreal medication for the advanced form of dry AMD. The practice also monitors research involving complementary pathways and other emerging approaches to retinal disease.

Research developments remain an area of interest for the firm. The Tucson practice has identified the Luna and Parasol clinical trials, along with gene therapy research for retinal conditions, as relevant subjects. Early gene therapy studies for dry AMD are examining subretinal administration, while clinical trials help evaluate safety and effectiveness.

Dr. Cameron Javid holds a clinical associate professorship in ophthalmology at the University of Arizona College of Medicine. Retina Associates is connected with organizations including the American Society of Retina Specialists, the American Academy of Ophthalmology, and the Arizona Ophthalmological Society.